Conexeu Sciences Inc (CNXU) Stock Price, Quote & News

Company Profile

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting ther...

Industry: Biotechnology

Sector: Healthcare

Phone: (604) 315-4722

Website: www.conexeu.com

Address:

50 West Liberty Street, Suite 880, Reno, United States

Salvadors_poppy Aug. 19 at 2:59 PM

$CNXU ….

0 · Reply

BioResearcher Aug. 19 at 2:19 PM

$CNXU This stock is trading like a pump and dump ! lol

0 · Reply

BioResearcher Aug. 19 at 1:24 PM

$CNXU This is a good article study about the booming market for medical aesthetics injectable market due to weight loss. (CNXU is entering this market with the recent success of their trial to restore large volume of tissue)

0 · Reply

BioResearcher Aug. 19 at 1:18 PM

$CNXU CNXU is targeting $ BILLIONS dollars market: "..rapid fat loss and muscle loss. This leads to facial volume loss, sagging skin, and an aged look called "Ozempic face." As a result, the aesthetic injectables market is booming..."

0 · Reply

dmplaw1 Aug. 18 at 10:59 PM

$CNXU I need to obtain more shares.

0 · Reply

BioResearcher Aug. 18 at 9:43 PM

$CNXU Awesome technology:

1 · Reply

BioResearcher Aug. 18 at 7:50 PM

$CNXU This company will be worth multi BILLIONs dollars ! Their technology is every woman's dream: the fountain of youth ! "Conexeu is targeting large, multi-billion-dollar end markets, including wound care, periodontal applications, and facial and body tissue restoration, including the tissue changes that can follow GLP-1 weight loss, with further expansion opportunities in 3D printing and biofabrication workflows and the veterinary market. The Company is advancing a predicate-based U.S. regulatory strategy with an anticipated 510(k) submission in early 2027 for its initial indication, subject to regulatory review."

0 · Reply

topstockalerts Aug. 17 at 1:56 PM

$CNXU double digits next

0 · Reply

STACKD0E Aug. 17 at 1:41 PM

$UPLD $UCL $UFI $CNXU 👁️

0 · Reply

ClassiTrader Aug. 14 at 8:17 PM

$CNXU 👀

0 · Reply

Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration

Jul 14, 2026, 8:30 AM EDT - 5 weeks ago

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

Jul 7, 2026, 9:00 AM EDT - 6 weeks ago

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill

Jun 25, 2026, 8:30 AM EDT - 7 weeks ago

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

2026-06-22T10:05:06.000Z - 2 months ago

Conexeu Sciences initiated with a Buy at H.C. Wainwright

2026-06-15T13:11:02.000Z - 2 months ago

Conexeu Sciences appoints David Bogart as chief commercial officer

Jun 15, 2026, 8:30 AM EDT - 2 months ago

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Jun 15, 2026, 8:00 AM EDT - 2 months ago

Conexeu Sciences Quarterly report: Q2 2026

2026-06-08T13:01:13.000Z - 2 months ago

Conexeu Sciences provides update on manufacturing scale up for wound care device

Jun 8, 2026, 8:30 AM EDT - 2 months ago

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Jun 3, 2026, 8:30 AM EDT - 2 months ago

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

May 27, 2026, 10:36 AM EDT - 3 months ago

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 8:30 AM EDT - 3 months ago

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 21, 2026, 12:02 PM EDT - 3 months ago

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

2026-05-21T15:45:30.000Z - 3 months ago

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

Salvadors_poppy Aug. 19 at 2:59 PM

$CNXU ….

0 · Reply

BioResearcher Aug. 19 at 2:19 PM

$CNXU This stock is trading like a pump and dump ! lol

0 · Reply

BioResearcher Aug. 19 at 1:24 PM

0 · Reply

BioResearcher Aug. 19 at 1:18 PM

0 · Reply

dmplaw1 Aug. 18 at 10:59 PM

$CNXU I need to obtain more shares.

0 · Reply

BioResearcher Aug. 18 at 9:43 PM

$CNXU Awesome technology:

1 · Reply

BioResearcher Aug. 18 at 7:50 PM

0 · Reply

topstockalerts Aug. 17 at 1:56 PM

$CNXU double digits next

0 · Reply

STACKD0E Aug. 17 at 1:41 PM

$UPLD $UCL $UFI $CNXU 👁️

0 · Reply

ClassiTrader Aug. 14 at 8:17 PM

$CNXU 👀

0 · Reply

Mikiminingmouse Aug. 13 at 8:02 AM

12 month study complete for $CNXU’s CXU platform! a great milestone checked off management execution stays super steady

0 · Reply

Mikiminingmouse Aug. 11 at 8:49 AM

$CNXU consolidating nicely in the $7 to $8 range. From technical analysis perspective, solid upside potential for this bio platform as clinical data matures.

0 · Reply

fional Jul. 30 at 4:52 PM

$CNXU Probably best to wait for the Full Stochastic to cross up over 20 to get a nice momo bounce and go from there. It tested the 10dma this morning and retreated; it will be a better buy signal when it is above the 10dma. No 50dma available on charts yet - too new. Speculative L/T but a nice momo bounce for S/T profit when it crosses the Stochastic noted above. GL all.

0 · Reply

cor1 Jul. 30 at 4:42 PM

$CNXU here is the marketing copy I got in the mail on conexeu.

0 · Reply

cor1 Jul. 30 at 4:39 PM

$CNXU Rich Dad / Poor Dad is pumping this one hard. And we have a daily hammer. Small cap, high risk. But probably worth riding the wave.

0 · Reply

Sarah147 Jul. 20 at 8:03 PM

$CNXU bottomed out?! loading some for a bounce

0 · Reply

topstockalerts Jul. 15 at 5:31 PM

Top Gainers PT2 $SLSN $TGHL $KUST $CNXU $GUTS

0 · Reply

topstockalerts Jul. 15 at 3:01 PM

Top Gainers PT2 $KUST $TGHL $CNXU $VTAK $APLM

0 · Reply

AnUnwiseInvestor Jul. 13 at 11:24 PM

$CNXU I got a letter in the mail from Robert Kiyosaki saying I should buy this.

1 · Reply

stocks_2watch Jul. 7 at 1:46 PM

Look…the preclinical data on their Ten-Minute Tissue injectable looks promising for wound care but $CNXU is still pre-revenue with a fast burn rate. The latest 10Q showed a $2.3M net loss for the quarter and zero revenue. expanding their footprint at the new Vancouver adMare M4 hub is a great long-term move to scale the CXU platform, preclinical biotech burns cash fast. Still have trust but being carefull

0 · Reply

Mikiminingmouse Jul. 3 at 3:21 PM

$CNXU Big step forward them, with opening of their new Vancouver R&D lab at the adMare hub. great to see them hit these operational milestones as they steadily build momentum toward their 2027 FDA 510(k) submission

0 · Reply

topstockalerts Jul. 2 at 12:35 PM

Pre Market Top Gainers PT2 $SURG $SDEV $TENX $UPXI $CNXU

0 · Reply

Market Cap	261.69M
Revenue (ttm)	0.00
Net Income (ttm)	-3.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	403,000
Avg Vol	130,230
Day's Range	N/A - N/A
Shares Out	26.76M
Stochastic %K	87%
Beta	N/A
Analysts	Sell
Price Target	$20.00